Arginine and ornithine supplementation increases growth hormone and insulin-like growth factor-1 serum levels after heavy-resistance exercise in strength-trained athletes

Journal of Strength and Conditioning Research

Volumn 24, Issue 4, 2010, Pages 1082-1090

  Zajac, Adam ^a   Poprzȩcki, Stanisław ^a   Zebrowska, Aleksandra ^a   Chalimoniuk, Malgorzata ^b   Langfort, Jozef ^a,b  

^a INSTITUTE OF SPORT SCIENCES   (Poland)

^b MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

Author keywords

Amino acids; Endocrine response; Strength training

Indexed keywords

ARGININE; GROWTH HORMONE; ORNITHINE; SOMATOMEDIN C;

ADULT; ANALYSIS OF VARIANCE; ANTHROPOMETRY; ARTICLE; ATHLETE; ATHLETIC PERFORMANCE; BLOOD; BODY MASS; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ENDURANCE; HUMAN; MALE; METABOLISM; METHODOLOGY; MUSCLE STRENGTH; ORAL DRUG ADMINISTRATION; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; RESISTANCE TRAINING;

ADMINISTRATION, ORAL; ANALYSIS OF VARIANCE; ANTHROPOMETRY; ARGININE; ATHLETES; ATHLETIC PERFORMANCE; BODY MASS INDEX; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MALE; MUSCLE STRENGTH; ORNITHINE; PHYSICAL ENDURANCE; RESISTANCE TRAINING; YOUNG ADULT;

EID: 77950670926     PISSN: 10648011     EISSN: None     Source Type: Journal    
DOI: 10.1519/JSC.0b013e3181d321ff     Document Type: Article

References (64)

1. Adams, GR. Invited review: autocrine/paracrine IGF-1 and skeletal muscle adaptation. J Appl Physiol 93: 1159-1167, 2002.
2. Alba-Roth, J, Muller, OA, Schopohl, J, and von Werder, VK. Arginine stimulates growth-hormone secretion by suppressing endogenous somatostatin secretion. J Clin Endocrinol Meth 67: 1186-1189, 1988.
3. Appleton, J. Arginine: clinical potential of semi-essential amino acid. Altern Med Rev 7: 512-522, 2002.
4. Ballard, TL, Clapper, JA, Specker, BL, Binkley, TL, and Vukovich, MD. Effect of protein supplementation during a 6-month strength and conditioning program on insulin-like growth factor I and markers of bone turnover in young adults. Am J Clin Nutr 81: 1442-1448, 2005.
5. Borst, SE, Hoyos, DV, Garzarella, L, Vincent, K, Pollock, BH, Lowenthal, DT, and Pollock, ML. Effects of resistance training on insulin-like growth factor and IGF binding proteins. Med Sci Sports Exerc 33: 648-653, 2001.
6. Buresh, R, Berg, K, and French, J. The effect of resistive exercise rest interval on hormonal response, strength, and hypertrophy with training. J Strength Cond Res 23: 62-71, 2009.
7. Campbell, BI, La Bounty, PM, and Roberts, M. The ergogenic potential of arginine. J Int Soc Sports Nutr 1: 35-38, 2004.
8. Castillo, L, Chapman, TE, Sanchez, M, Yu, YM, Burke, JF, Ajami, AM, Vogt, J, and Young, VR. Plasma arginine and citrulline kinetics in adults given adequate and arginine free diets. Proc Natl Acad Sci USA 90: 7749-7753, 1993.
9. Chwalbinska-Moneta, J, Kruk, B, Nazar, K, Krzemiń ski, K, Kaciuba-Uściłko, H, and Ziemba, A. Early effects of short-term endurance training on hormonal responses to graded exercise. J Physiol Pharmacol 56: 87-99, 2005.
10. Closs, EI, Simon, A, Vecony, N, and Rotmann, A. Plasma membrane transport for arginine. J Nutr 134: S2752-S2759, 2004.
11. Collier, SR, Casey, DP, and Kanaley, JA. Growth hormone responses to varying doses of oral arginine. Growth Horm IGF Res 15: 136-139, 2005.
12. Collier, SR, Collins, E, and Kanaley, JA. Oral arginine attenuates the growth hormone response to resistance exercise. J Appl Physiol 101:848-852, 2006.
13. De Castro Barbosa, T, Nicoletti de Carvalho, JE, Poyares, LL, Bordin, S, Fabres Machado, U, and Nunes, MT. Potential role of growth hormone in impairment of insulin signaling in skeletal muscle, adipose tissue, and liver of rats chronically treated with arginine. Endocrinology 150: 2080-2086, 2009.
14. De Vries, WR, Abdesselam, SA, Schers, TJ, Maas, HC, Osman-Dualeh, M, Maitimu, I, and Koppeschaar, HP. Complete inhibition of hypothalamic somatostatin activity is only partially responsible for the growth hormone response to strenuous exercise. Metabolism 51: 1093-1096, 2002.
15. Evain-Brion, D, Donnadieu, M, Roger, M, and Job, JC. Simultaneous study of somatotrophic and corticotrophic pituitary secretions during ornithine infusion test. Clin Endocrinol 17: 119-122, 1982.
16. Filaire, E, Jouanel, P, Colombier, M, Bégue, RJ, and Lac, G. Effects of 16 weeks of training prior to a major competition on hormonal and biochemical parameters in young elite gymnasts. J Pediatr Endocrinol Metab 16: 741-750, 2003.
17. Fischer, F, Schulte, H, Mohan, S, Tataru, M, Köhler, E, Assmann, G, and Eckardstein, A. Association of insulin-like growth factors, insulin growth factor binding proteins and acid-labile subunit with coronary heart disease. Clin Endocrinol 61: 595-602, 2004.
18. Fogelholm, GM, Näveri, HK, Kiilavuori, KT, and Härkönen, MH. Low-dose amino acid supplementation: No effects on serum human growth hormone and insulin in male weightlifters. Int J Sport Nutr 3: 290-297, 1993.
19. Fry, AC, Kraemer, WJ, Stone, MH, Warren, BJ, Kearney, JT, Maresh, CM, Weseman, CA, and Fleck, SJ. Endocrine and performance responses to high volume training and amino acid supplementation in elite junior weightlifters. Int J Sport Nutr 3: 306-322, 1993.
20. Fryburg, DA. Insulin-like growth factor I exerts growth hormoneand insulin-like actions on human muscle protein metabolism. Am J Physiol 267: E331-E336, 1994.
21. Gentili, A, Muligan, T, Godschalk, M, Clore, J, Patrie, J, Iranmanesh, A, and Veldhis, JD. Unequal impact of short-term testosterone repletion on the somatotropic axis of young and older men. J Clin Endocrinol Meth 87: 825-834, 2002.
22. Gibney, J, Wolthers, T, Johannsson, G, Umpleby, AM, and Ho, KKY. Growth hormone and testosterone interact positively to enhance protein and energy metabolism in hypopituitary men. Am J Physiol Endocrinol Metab 289: E266-E271, 2005.
23. Häkkinen, K and Pakarinen, A. Acute hormonal responses to two different fatiguing heavy-resistance protocols in male athletes. J Appl Physiol 74: 882-887, 1993.
24. Hameed, M, Lange, KH, Andersen, JL, Schjerling, P, Kjaer, M, Harridge, SD, and Goldspink, G. The effect of recombinant human growth hormone and resistance training on IGF-1 mRNA expression in the muscle of elderly men. J Physiol 555: 231-240, 2004.
25. Hameed, M, Orrell, RW, Cobbold, M, Goldspink, G, and Harridge, SD. Expression of IGF-I splice variants in young and old human skeletal muscle after high resistance exercise. J Physiol 547: 247-254, 2003.
26. Harridge, SDR. Plasticity of human skeletal muscle: gene expression in vivo function. Exp Physiol 92: 783-797, 2007.
27. Heinemeier, KM, Olesen, JL, Schjerling, P, Haddad, F, Langberg, H, Baldwin, KM, and Kjaer, M. Short-term strength training and the expression of myostatin and IGF-I isoforms in rat muscle and tendon: differential effects of specific contractions types. J Appl Physiol 102: 573-581, 2007.
28. Jones, JI and Clemmoms, DR. Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev 16: 3-34, 1995.
29. Kanalay, JA. Growth hormone, arginine and exercise. Curr Opin Clin Nutr Metab Care 11: 50-54, 2008.
30. Koziris, LP, Hickson, RC, Chatterton, RT Jr, Groseth, RT, Christie, JM, Goldflies, DG, and Unterman, TG. Serum levels of total and free IGF-I and IGFBP-3 are increased and maintained in longterm training. J Appl Physiol 86: 1436-1442, 1999.
31. Kraemer, WJ, Aguilera, BA, Terada, M, Newton, RU, Lynch, JM, Rosendaal, G, McBride, JM, Gordon, SE, and Häkkinen, K. Responses of IGF-I to endogenous increases in growth hormones after heavy-resistance exercise. J Appl Physiol 79: 1310-11305, 1995.
32. Kraemer, WJ, Harman, FS, Vos, NH, Gordon, SE, Nindl, BC, Marx, JO, Gó mez, AL, Volek, JS, Ratamess, NA, Mazzetti, SA, Bush, JA, Dohi, K, Newton, RU, and Häkkinen, K. Effects of exercise and alkalosis on serum insulin-like growth factor I and IGF-binding protein-3. Can J Appl Physiol 25: 127-138, 2000.
33. Kraemer, WJ, Marchitelli, L, Gordon, SE, Harman, E, Dziados, JM, Mello, R, Frykman, P, McCurry, D, and Fleck, SJ. Hormonal and growth factor responses to heavy resistance exercise protocols. J Appl Physiol 69: 1442-1450, 1990.
34. Kraemer, WJ and Ratamess, NA. Hormonal responses and adaptations to resistance exercise and training. Sports Med 35: 339-361, 2005.
35. Le Boucher, J and Cynober, LA. Ornithine a-ketoglutarate: The puzzle. Nutrition 14: 870-873, 1998.
36. Lee, S, Barton, ER, Sweeney, HL, and Farrar, RP. Viral expression of insulin-like growth factor-I enhances muscle hypertrophy in resistance-trained rats. J Appl Physiol 96: 1097-1104, 2004.
37. Le Roith, D, Bondy, C, Yakar, S, Liu, J, and Butler, A. The somatomedin hypothesis. Endocr Rev 22: 53-74, 2001.
38. Lind, DS. Arginine and cancer. J Nutr 134: S2837-S2841, 2004.
39. Loche, S, Colao, A, Cappa, M, Bellone, J, Aimeretti, G, Farello, A, Faedda, Lombardi, G, Deghenghi, R, and Ghigo, E. The growth hormone response to hexarelin in children: reproducibility and effect of sex steroids. J Clin Endocrinol Meth 82: 87-91, 1997.
40. Maas, HCM, de Vries, WR, Maitimu, I, Bol, E, Bowers, CY, and Koppeschaar, HP. Growth hormone responses during strenuous exercise: The role of GH-releasing hormone and GH-releasing peptide-2. Med Sci Sports Exerc 32: 1226-1232, 2000.
41. Manetta, J, Brun, JF, Fedou, C, Maïmoun, L, Prefaut, C, and Mercier, J. Serum levels of insulin-like growth factor-I (IGF-I), and IGF-binding proteins-1 and-3 in middle-aged and young athletes versus sedentary men: Relationship with glucose disposal. Metabolism 52: 821-826, 2003.
42. Manetta, J, Brun, JF, Maïmoun, L, Callis, A, Prefaut, C, and Mercier, J. Effect of training on the GH/IGF-I axis during exercise in middle-aged men: Relationship to glucose homeostasis. Am J Physiol Endocrinol 283: 929-936, 2002.
43. May, PE, Barber, A, D'Olimpio, JT, Hourihane, A, and Abumrad, NN. Reversal of cancer-related wasting using oral supplementation with a combination of beta-hydroxy-beta-methylbutyrate, arginine, and glutamine. Am J Surg 183: 471-479, 2002.
44. Nemet, D, Connolly, PH, Pontello-Pescatello, AM, Rose-Gottron, CH, Larson, JK, Galassetti, P, and Cooper, DM. Negative energy balance plays a major role in the IGF-I response to exercise training. J Appl Physiol 96: 276-282, 2004.
45. Nindl, BC, Kraemer, WJ, and Hymer, WC. Immunofunctional vs immunoreactive growth hormone responses after resistance exercise in men and women. Growth Horm IGF Res 10: 99-103, 2000.
46. Nindl, BC, Kraemer, WJ, Marx, JO, Arciero, PJ, Dohi, K, Kellog MD, and Loomis, GA. Overnight responses of the circulating IGF-I system after acute, heavy-resistance exercise. J Appl Physiol 90: 1319-1326, 2001.
47. Penalva, A, Pombo, M, Carballo, A, Barreiro, J, Casanueva, FF, and Dieguez, C. Influence of sex and adrenergic pathways on the growth hormone response to GHRP-6. Clin Endocrinol 38: 87-91, 1993.
48. Reyes, AA, Karl, IE, and Klahr, S. Role of arginine in health and in renal disease. Am J Physiol 267: F331-F346, 1994.
49. Rosenfeld, RG, Wilson, DM, Dollar, LA, Bennett, A, and Hintz, RL. Both human pituitary growth hormone and recombinant DNAderived human growth hormone cause insulin resistance at a postreceptor site. J Clin Endocrinol Metab 54: 1033-1038, 1982.
50. Schaefer, A, Piquard, F, Geny, B, Doutreleau, S, Lampert, E, Mettauer, B, and Lonsdorfer, J. l-Arginine reduces exercise-induced increase in plasma lactate and ammonia. Int J Sports Med 23: 403-407, 2002.
51. Schwarz, AJ, Brasel, JA, Hintz, RL, Mohan, S, and Cooper, DM. Acute effect of brief low-and high-intensity exercise on circulating insulin-like growth factor (IGF) I, II, and IGF-binding protein-3 and its proteolysis in young healthy men. J Clin Endocrinol Metab 81: 3492-3497, 1996.
52. Sheffield-Moore, M and Urban, J. An overview of the endocrinology of skeletal muscle. Trends Endocrinol Metab 15: 110-115, 2004.
53. Thissen, JP, Ketelslegers, JM, and Underwood, LE. Nutritional regulation of the insulin-like growth factors. Endocr Rev 15: 80-101, 1994.
54. Tong, BC and Barbul, A. Cellular and physiological effects of arginine. Mini Rev Med Chem 4: 823-832, 2004.
55. Valverde, I, Penalva, A, and Dieguez, C. Influence of different serotonin receptor subtypes on growth hormone secretion. Neuroendocrinology 71: 145-153, 2000.
56. Visek, WJ. Dietary protein and experimental carcinogenesis. Adv Exp Med Biol 206: 163-186, 1986.
57. Vorwerk, P, Yamanaka, Y, Spagnolli, A, Oh, Y, and Rosenfeld, RG. Insulin IGF binding by IGFBP-3 fragments derived from proteolysis, baculovirus expression and normal urine. J Clin Endocrinol Metab 83: 1392-1395, 1998.
58. Weltman, A, Weltman, JY, Womack, CJ, Davis, SE, Blumer, JL, Gaesser, GA, and Hartman, ML. Exercise training decreases the growth hormone (GH) to acute constant-load exercise. Med Sci Sports Exerc 29: 669-676, 1997.
59. Wideman, L, Weltman, JY, Hartman, ML, Veldhuis, JD, and Weltman, A. Growth Hormone release during acute and chronic aerobic and resistance exercise. Sports Med 32: 987-1004, 2002.
60. Wideman, L, Weltman, JY, Patrie, JT, Bowers, CY, Shah, N, Story, S, Veldhuis, JD, and Weltman, A. Synergy of l-arginine and GHrp-2 stimulation of growth hormone in men and women: modulation by exercise. Am J Physiol Regul Integr Comp Physiol 279: R1467-R1477, 2000.
61. Willoughby, DS, Taylor, M, and Taylor, L. Glucocorticoid receptor and ibiquitin expression after repeated eccentric exercise. Med Sci Sports Exerc 35: 2023-2031, 2003.
62. Wilmore, D. Eternal and parentelal arginine supplementation to improve medical outcomes in hospitalized patients. J Nutr 134: S2863-S2867, 2004.
63. Witte, MB and Barbul, A. Arginine physiology and its implication for wound healing. Wound Repair Rege 11: 419-423, 2003.
64. Zebrowska, A, Ga sior, Z, and Langfort, J. Serum IGF-I and hormonal responses to incremental exercise in athletes with and without left ventricular hypertrophy. J Sports Sci Med 8: 67-76, 2009.